CMIRPS Program Overview
The Canadian Medication Incident Reporting and Prevention System (CMIRPS) is a collaborative pan-Canadian program of Health Canada, ISMP Canada, Canadian Institute for Health Information, Patients for Patient Safety Canada and Healthcare Excellence Canada. The goal of CMIRPS is to reduce and prevent harmful medication incidents in Canada.CMIRPS Program Overview
Melissa Sheldrick’s Story
Melissa Sheldrick is the first Patient and Family Advisor on the ISMP Canada team. She has been a strong advocate of patient safety and medication safety after the loss of her son, Andrew Sheldrick, to an error made during the dispensing of his compounded medication. Since then, she has worked nationally and internationally to call for action and improvement in medication safety. Since 2019, Melissa has been bringing her lived experience to ISMP Canada.
CMIRPS Evaluation Report
Prairie Research Associates (PRA), an independent research firm, conducted an evaluation in 2022 of the relevance, usefulness, and effectiveness of the CMIRPS products/services offered by ISMP Canada. PRA determined that there is vast evidence of ISMP Canada activities positively impacting the Canadian health system. ISMP Canada CMIRPS resources, activities, and products have been integrated into and referenced in several national and provincial standard and required practice, guideline and best practice, product improvement, and policy and procedure documents and committees over the past 10 years. Additionally, the opioid stewardship case scenario completed as part of this evaluation showed direct impact of an ISMP Canada safety bulletin on patients. Finally, ISMP Canada is also impacting the Canadian health system by transferring knowledge to medical researchers through journal publications they have co-authored or been referenced in. See the Executive Summary of the evaluation report for more information.CMIRPS Evaluation Report